344 related articles for article (PubMed ID: 28659479)
41. Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles.
Dolnik O; Kolesnikova L; Stevermann L; Becker S
J Virol; 2010 Aug; 84(15):7847-56. PubMed ID: 20504928
[TBL] [Abstract][Full Text] [Related]
42. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
43. The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis.
Kirchdoerfer RN; Moyer CL; Abelson DM; Saphire EO
PLoS Pathog; 2016 Oct; 12(10):e1005937. PubMed ID: 27755595
[TBL] [Abstract][Full Text] [Related]
44. Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells.
Shabman RS; Jabado OJ; Mire CE; Stockwell TB; Edwards M; Mahajan M; Geisbert TW; Basler CF
mBio; 2014 Nov; 5(6):e02011. PubMed ID: 25370495
[TBL] [Abstract][Full Text] [Related]
45. RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.
Biedenkopf N; Schlereth J; Grünweller A; Becker S; Hartmann RK
J Virol; 2016 Aug; 90(16):7481-7496. PubMed ID: 27279615
[TBL] [Abstract][Full Text] [Related]
46. Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein.
DiCarlo A; Möller P; Lander A; Kolesnikova L; Becker S
Virol J; 2007 Oct; 4():105. PubMed ID: 17958906
[TBL] [Abstract][Full Text] [Related]
47. Unveiling a Drift Resistant Cryptotope within
Garza JA; Taylor AB; Sherwood LJ; Hart PJ; Hayhurst A
Front Immunol; 2017; 8():1234. PubMed ID: 29038656
[TBL] [Abstract][Full Text] [Related]
48. Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells.
Bharat TA; Riches JD; Kolesnikova L; Welsch S; Krähling V; Davey N; Parsy ML; Becker S; Briggs JA
PLoS Biol; 2011 Nov; 9(11):e1001196. PubMed ID: 22110401
[TBL] [Abstract][Full Text] [Related]
49. Structure of the Ebola VP35 interferon inhibitory domain.
Leung DW; Ginder ND; Fulton DB; Nix J; Basler CF; Honzatko RB; Amarasinghe GK
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):411-6. PubMed ID: 19122151
[TBL] [Abstract][Full Text] [Related]
50. Structures of Ebola and Reston Virus VP35 Oligomerization Domains and Comparative Biophysical Characterization in All Ebolavirus Species.
Zinzula L; Nagy I; Orsini M; Weyher-Stingl E; Bracher A; Baumeister W
Structure; 2019 Jan; 27(1):39-54.e6. PubMed ID: 30482729
[TBL] [Abstract][Full Text] [Related]
51. Structural insights into the interactions between lloviu virus VP30 and nucleoprotein.
Sun W; Luan F; Wang J; Ma L; Li X; Yang G; Hao C; Qin X; Dong S
Biochem Biophys Res Commun; 2022 Aug; 616():82-88. PubMed ID: 35649303
[TBL] [Abstract][Full Text] [Related]
52. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
53. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
[TBL] [Abstract][Full Text] [Related]
54. Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells.
Dolnik O; Kolesnikova L; Welsch S; Strecker T; Schudt G; Becker S
PLoS Pathog; 2014 Oct; 10(10):e1004463. PubMed ID: 25330247
[TBL] [Abstract][Full Text] [Related]
55. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
[TBL] [Abstract][Full Text] [Related]
56. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
[TBL] [Abstract][Full Text] [Related]
57. Characterization of filovirus protein-protein interactions in mammalian cells using bimolecular complementation.
Liu Y; Stone S; Harty RN
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S817-24. PubMed ID: 21987757
[TBL] [Abstract][Full Text] [Related]
58. Structure of the Ebola virus polymerase complex.
Yuan B; Peng Q; Cheng J; Wang M; Zhong J; Qi J; Gao GF; Shi Y
Nature; 2022 Oct; 610(7931):394-401. PubMed ID: 36171293
[TBL] [Abstract][Full Text] [Related]
59. Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene.
Edwards MR; Vogel OA; Mori H; Davey RA; Basler CF
mBio; 2022 Oct; 13(5):e0224322. PubMed ID: 35997284
[TBL] [Abstract][Full Text] [Related]
60. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
